NZ508519A - Preparation of human papillomavirus E1 having helicase activity and method therefor - Google Patents

Preparation of human papillomavirus E1 having helicase activity and method therefor

Info

Publication number
NZ508519A
NZ508519A NZ508519A NZ50851999A NZ508519A NZ 508519 A NZ508519 A NZ 508519A NZ 508519 A NZ508519 A NZ 508519A NZ 50851999 A NZ50851999 A NZ 50851999A NZ 508519 A NZ508519 A NZ 508519A
Authority
NZ
New Zealand
Prior art keywords
seq
protein
hpv
papillomavirus
helicase
Prior art date
Application number
NZ508519A
Other languages
English (en)
Inventor
Alex Pelletier
Chris M Farnet
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Publication of NZ508519A publication Critical patent/NZ508519A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NZ508519A 1998-05-01 1999-04-28 Preparation of human papillomavirus E1 having helicase activity and method therefor NZ508519A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8394298P 1998-05-01 1998-05-01
PCT/CA1999/000389 WO1999057283A1 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Publications (1)

Publication Number Publication Date
NZ508519A true NZ508519A (en) 2003-12-19

Family

ID=22181652

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ508519A NZ508519A (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus E1 having helicase activity and method therefor

Country Status (9)

Country Link
US (1) US6306580B1 (cg-RX-API-DMAC7.html)
EP (1) EP1073750A1 (cg-RX-API-DMAC7.html)
JP (1) JP2002513813A (cg-RX-API-DMAC7.html)
AU (1) AU767903B2 (cg-RX-API-DMAC7.html)
CA (1) CA2326402A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0101396A3 (cg-RX-API-DMAC7.html)
IL (1) IL139270A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ508519A (cg-RX-API-DMAC7.html)
WO (1) WO1999057283A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140524A0 (en) * 1998-07-21 2002-02-10 Boehringer Ingelheim Ca Ltd Regions of papilloma virus e1 helicase involved in e1 oligomerization
HUP0201512A3 (en) 1999-06-17 2010-01-28 Boehringer Ingelheim Ca Ltd New atpase assay
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
US7167801B2 (en) 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
WO2003068940A2 (en) * 2002-02-14 2003-08-21 Curagen Corporation Complexes and methods of using same
USD1070308S1 (en) * 2023-07-13 2025-04-15 Wolverine Outdoors, Inc. Footwear sole
USD1067593S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole
USD1067594S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464936A (en) * 1990-12-21 1995-11-07 Cetus Oncology Corporation Compositions for identification of papillomavirus replication inhibitors

Also Published As

Publication number Publication date
CA2326402A1 (en) 1999-11-11
EP1073750A1 (en) 2001-02-07
HUP0101396A2 (hu) 2001-08-28
AU3592399A (en) 1999-11-23
AU767903B2 (en) 2003-11-27
US6306580B1 (en) 2001-10-23
JP2002513813A (ja) 2002-05-14
WO1999057283A1 (en) 1999-11-11
IL139270A0 (en) 2001-11-25
HUP0101396A3 (en) 2006-03-28

Similar Documents

Publication Publication Date Title
Vande Pol et al. Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif
Hughes et al. E1 protein of human papillomavirus is a DNA helicase/ATPase
Klinedinst et al. Helicase-primase complex of herpes simplex virus type 1: a mutation in the UL52 subunit abolishes primase activity
Gross et al. The nucleoside triphosphatase and helicase activities of vaccinia virus NPH-II are essential for virus replication
Bierle et al. Double-stranded RNA binding by the human cytomegalovirus PKR antagonist TRS1
AU767903B2 (en) Preparation of human papillomavirus E1 having helicase activity and method therefor
US20040110126A1 (en) Hcv polymerase inhibitor assay
Yang et al. Biochemical characterization of Periplaneta fuliginosa densovirus non-structural protein NS1
Rocque et al. Replication-associated activities of purified human papillomavirus type 11 E1 helicase
AU714821B2 (en) Methods, kits, and compositions for diagnosing papillomavirus infection
Cochrane et al. Stable complex formation between HIV Rev and the nucleosome assembly protein, NAP1, affects Rev function
MXPA00010584A (en) Preparation of human papillomavirus e1 having helicase activity and method therefor
US6518014B1 (en) Hepadnavirus cores
US6916622B2 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
US6322792B1 (en) Rhadino virus LANA acts in trans on a unit of rhadino virus DNA to mediate efficient episome persistance
AU2004200590A1 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
AU2002244566B2 (en) Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV
MXPA01000693A (en) Regions of papilloma virus e1 helicase involved in e1 oligomerization
WO1999057536A2 (en) Cyclin activation kinase (cak) from human pathogens, and uses related thereto
WO1998004747A9 (en) Ul97 fusion proteins and methods of use
YOON et al. Expression of Human Papillomavirus Type 16 E6 Protein in Escherichia coli
Han et al. RNA-Stimulated ATPase and RNA Helicase
AU2002244566A1 (en) Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV
KR19990086165A (ko) Cdk4 의 저해제인 p16의 카복시말단이 절단된 결손형cδp16 단백질, 그의 유전자

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)